FDA-approved Crohn's treatments include biologic therapies (infliximab, adalimumab, vedolizumab, ustekinumab, risankizumab), JAK inhibitors (upadacitinib), corticosteroids for induction (budesonide, prednisone), and immunomodulators (azathioprine, methotrexate)
10.1016/j.jep.2015.04.028 34 JacobsB
Girardin SE, Travassos LH, Herv M, Blanot D, Boneca IG, Philpott DJ, et al
That is a genetic-knockdown study in mice, not a drug trial: it tells you the target is real and metabolically meaningful in an animal model, but it does not test a drug, a dose, or a route
Novo Nordisk Colombia covers the open access fees for this publication and paid for part of the statistical analysis, medical writing, and editorial assistance